Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and noninvasively ...

Chief Executive Officer Craig Parker used a discussion at a 2026 investor summit to outline the company’s focus on Wnt pathway biology and antibody engineering, with an emphasis on retinal vascular ...

Analysis of the final APEX Phase 1b clinical results obtained with KSI-101 (Kodiak Sciences Inc.) evaluated to treat macular edema secondary to inflammation (MESI) showed that at week 24 well over ...

Pakistan witnessed escalating unrest after health concerns surrounding former Prime Minister Imran Khan triggered indefinite protests by the Pakistan Tehreek-e-Insaf across Islamabad, Karachi and ...

Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

Central vision loss from Age-related Macular Degeneration can begin subtly, faces blur, words distort, yet side vision ...

As the use of glaucoma drainage implants (GDIs) continues to expand in clinical practice, surgeons are becoming more attuned ...

EyePoint Pharmaceuticals (NASDAQ:EYPT) used a presentation at the Guggenheim Emerging Biotech Emerging Outlook Biotech Summit ...

Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and ...

Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.

Discover how saliva testing detects oral and systemic diseases early. Learn about the mouth-body connection and the power of salivary biomarkers. [ ...

Researchers have developed a miniature optical fiber biosensor capable of detecting key biomarkers of diabetic retinopathy ...